Bacterial chaperones CsgE and CsgC differentially modulate human α-Synuclein amyloid formation via transient contacts

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Chorell, Erik ^a   Andersson, Emma ^a   Evans, Margery L ^b   Jain, Neha ^b   Götheson, Anna ^a   Aden, Jörgen ^a   Chapman, Matthew R ^b   Almqvist, Fredrik ^a   Wittung Stafshede, Pernilla ^a,c  

^a UMEÅ UNIVERSITY   (Sweden)

^b UNIVERSITY OF MICHIGAN   (United States)

^c CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID; BACTERIAL PROTEIN; CHAPERONE; PROTEIN CSGC; PROTEIN CSGE; UNCLASSIFIED DRUG; CARRIER PROTEIN; CSGC PROTEIN, E COLI; CSGE PROTEIN, E COLI; ESCHERICHIA COLI PROTEIN; HYBRID PROTEIN; PROTEIN BINDING;

ARTICLE; ATOMIC FORCE MICROSCOPY; CENTRIFUGATION; CIRCULAR DICHROISM; CONTROLLED STUDY; ESCHERICHIA COLI; FLUORESCENCE MICROSCOPY; HYDRODYNAMICS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OLIGOMERIZATION; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; ANIMAL; CHEMISTRY; GENETICS; HUMAN; METABOLISM; MOUSE; PROTEIN MULTIMERIZATION; PROTEIN SECONDARY STRUCTURE; PROTEINOSIS;

ALPHA-SYNUCLEIN; ANIMALS; ESCHERICHIA COLI PROTEINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; MICE; MOLECULAR CHAPERONES; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; PROTEIN AGGREGATION, PATHOLOGICAL; PROTEIN BINDING; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT FUSION PROTEINS;

EID: 84949213607     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140194     Document Type: Article

References (44)

1. Fink A.L., The aggregation and fibrillation of alpha-synuclein. Acc Chem Res, 2006. 39(9): p. 628-34.
2. Kayed R., et al., Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science, 2003. 300(5618): p. 486-9.
3. Winner B., et al., In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci U S A. 108(10): p. 4194-9. doi: 10.1073/pnas.1100976108
4. Eliezer D., et al., Conformational properties of alpha-synuclein in its free and lipid-Associated states. J Mol Biol, 2001. 307(4): p. 1061-73.
5. Hoyer W., et al., Impact of the acidic C-Terminal region comprising amino acids 109-140 on alpha-synuclein aggregation in vitro. Biochemistry, 2004. 43(51): p. 16233-42.
6. Galvin J.E., et al., Pathobiology of the Lewy body. Adv Neurol, 1999. 80: p. 313-24.
7. Braga C.A., et al., The Anti-Parkinsonian Drug Selegiline Delays the Nucleation Phase of α-Synuclein Aggregation Leading to the Formation of Nontoxic Species. J Mol Biol, 2011. 405(1): p. 254-273. doi: 10.1016/j.jmb.2010.10.027
8. Hong D.-P., Fink A.L., and Uversky V.N., Structural Characteristics of α-Synuclein Oligomers Stabilized by the Flavonoid Baicalein. J Mol Biol, 2008. 383(1): p. 214-223. doi: 10.1016/j.jmb.2008.08.039
9. Li J., et al., Rifampicin Inhibits α-Synuclein Fibrillation and Disaggregates Fibrils. Chemistry & biology, 2004. 11(11): p. 1513-1521.
10. Horvath I., et al., Mechanisms of Protein Oligomerization: Inhibitor of Functional Amyloids Templates α-Synuclein Fibrillation. Journal of the American Chemical Society, 2012. 134(7): p. 3439-3444. doi: 10. 1021/ja209829m
11. Horvath I., et al., Modulation of alpha-synuclein fibrillization by ring-fused 2-pyridones: Templation and inhibition involve oligomers with different structure. Arch Biochem Biophys, 2013. 532(2): p. 84-90. doi: 10.1016/j.abb.2013.01.012
12. Evans M.L. and Chapman M.R., Curli biogenesis: order out of disorder. Biochim Biophys Acta, 2014. 1843(8): p. 1551-8. doi: 10.1016/j.bbamcr.2013.09.010
13. Larsen P., et al., Amyloid adhesins are abundant in natural biofilms. Environ Microbiol, 2007. 9(12): p. 3077-90.
14. Chapman M.R., et al., Role of Escherichia coli curli operons in directing amyloid fiber formation. Science, 2002. 295(5556): p. 851-5.
15. DePas W.H., et al., Iron induces bimodal population development by Escherichia coli. Proc Natl Acad Sci U S A, 2013. 110(7): p. 2629-34. doi: 10.1073/pnas.1218703110
16. Hammer N.D., Schmidt J.C., and Chapman M.R., The curli nucleator protein, CsgB, contains an amyloidogenic domain that directs CsgA polymerization. Proc Natl Acad Sci U S A, 2007. 104(30): p. 12494-9
17. Hammer N.D., et al., The C-Terminal repeating units of CsgB direct bacterial functional amyloid nucleation. J Mol Biol, 2012. 422(3): p. 376-89. doi: 10.1016/j.jmb.2012.05.043
18. Wang X., et al., In vitro polymerization of a functional Escherichia coli amyloid protein. J Biol Chem, 2007. 282(6): p. 3713-9.
19. Dueholm M.S., et al., Fibrillation of the Major Curli Subunit CsgA under a Wide Range of Conditions Implies a Robust Design of Aggregation. Biochemistry, 2011. 50(39): p. 8281-90. doi: 10.1021/bi200967c
20. Evans M.L., et al., The Bacterial Curli System Possesses a Potent and Selective Inhibitor of Amyloid Formation. Mol Cell, 2015.
21. Andersson E.K., et al., Modulation of curli assembly and pellicle biofilm formation by chemical and protein chaperones. Chem Biol, 2013. 20(10): p. 1245-54. doi: 10.1016/j.chembiol.2013.07.017
22. Taylor J.D., et al., Atomic resolution insights into curli fiber biogenesis. Structure, 2011. 19(9): p. 1307-doi: 10.1016/j.str.2011.05.015
23. Goyal P., et al., Structural and mechanistic insights into the bacterial amyloid secretion channel CsgG. Nature, 2014. 516(7530): p. 250-3. doi: 10.1038/nature13768
24. Nenninger A.A., et al., CsgE is a curli secretion specificity factor that prevents amyloid fibre aggregation. Mol Microbiol, 2011. 81(2): p. 486-99. doi: 10.1111/j.1365-2958.2011.07706.x
25. Salgado P.S., et al., Extending the usability of the phasing power of diselenide bonds: SeCys SAD phasing of CsgC using a non-Auxotrophic strain. Acta Crystallogr D Biol Crystallogr, 2011. 67(Pt 1): p. 8-13. doi: 10.1107/S0907444910042022
26. Delaglio F., et al., NMRPipe: A multidimensional spectral processing system based on UNIX pipes. J Biomol NMR, 1995. 6(3): p. 277-93.
27. Helgstrand M., et al., Ansig for Windows: An interactive computer program for semiautomatic assignment of protein NMR spectra. J Biomol NMR, 2000. 18(4): p. 329-36.
28. Berger S. and Braun S., 200 and More NMR Experiments. A Practical Course. 2004, Weinheim, Germany: Wiley-VHC.
29. Price W.S., Pulsed-field gradient nuclear magnetic resonance as a tool for studying translational diffusion: Part II. Experimental aspects. Concepts Magn. Reson, 1998. 10: p. 197-237.
30. Stejskal E.O. and Tanner J.E., Spin diffusion measurements: spin echoes in the presence of a timedependent field gradient. J Chem Phys, 1965. 42: p. 288-292.
31. Kestin J., Sokolov M., and Wakeham W.A., Viscosity of Liquid Water in the Range-8C to 150C. J Phys Chem, 1978. 7: p. 941-948.
32. Naiki H., et al., Fluorometric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem, 1989. 177(2): p. 244-9.
33. Dedmon M.M., et al., Heat shock protein 70 inhibits alpha-synuclein fibril formation via preferential binding to prefibrillar species. J Biol Chem, 2005. 280(15): p. 14733-40.
34. Wu K.P. and Baum J., Backbone assignment and dynamics of human alpha-synuclein in viscous 2 M glucose solution. Biomol NMR Assign, 2011. 5(1): p. 43-6. doi: 10.1007/s12104-010-9263-4
35. Daturpalli S., et al., Hsp90 inhibits alpha-synuclein aggregation by interacting with soluble oligomers. J Mol Biol, 2013. 425(22): p. 4614-28. doi: 10.1016/j.jmb.2013.08.006
36. Cegelski L., et al., Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation. Nat Chem Biol, 2009. 5(12): p. 913-9. doi: 10.1038/nchembio.242
37. Chi Y.C., et al., Residue histidine 50 plays a key role in protecting alpha-synuclein from aggregation at physiological pH. J Biol Chem, 2014. 289(22): p. 15474-81. doi: 10.1074/jbc.M113.544049
38. Ahmad A., DnaK/DnaJ/GrpE of Hsp70 system have differing effects on alpha-synuclein fibrillation involved in Parkinson's disease. Int J Biol Macromol, 2010. 46(2): p. 275-9. doi: 10.1016/j.ijbiomac. 2009.12.017
39. Breydo L., Morgan D., and Uversky V.N., Pseudocatalytic Antiaggregation Activity of Antibodies: Immunoglobulins can Influence alpha-Synuclein Aggregation at Substoichiometric Concentrations. Mol Neurobiol, 2015.
40. Gerard M., et al., The aggregation of alpha-synuclein is stimulated by FK506 binding proteins as shown by fluorescence correlation spectroscopy. FASEB J, 2006. 20(3): p. 524-6.
41. Karamanos T.K., et al., Visualization of transient protein-protein interactions that promote or inhibit amyloid assembly.Mol Cell, 2014. 55(2): p. 214-26. doi: 10.1016/j.molcel.2014.05.026
42. Turnbaugh P.J., et al., A core gut microbiome in obese and lean twins. Nature, 2009. 457(7228): p. 480-4. doi: 10.1038/nature07540
43. Holmqvist S., et al., Direct evidence of Parkinson pathology spread from the gastrointestinal tract to the brain in rats. Acta Neuropathol, 2014.
44. Visanji N.P., et al., The prion hypothesis in Parkinson's disease: Braak to the future. Acta Neuropathol Commun, 2013. 1(1): p. 2.